Phase 2a Safety Study of a Vaginal Matrix Ring Containing Dapivirine in a Postmenopausal Female Population
Phase of Trial: Phase II
Latest Information Update: 04 Oct 2018
Price : $35 *
At a glance
- Drugs Dapivirine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 04 Oct 2018 Results published in the Clinical Infectious Diseases
- 25 Feb 2016 Results assessing adherence and acceptability across study group and in random subset of 24 subjects presented at the 23rd Conference on Retroviruses and Opportunistic Infections.
- 25 Feb 2016 Results assesing safety and pharmacokinetics presented at the 23rd Conference on Retroviruses and Opportunistic Infections.